Fierce Pharma Biopharma News & Insights
WEB3 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Pharma | Fierce Pharma
WEBAug 26, 2024 · Theratechnologies' reliance on a small pool of contract manufacturers has come back to bite the Quebecois biopharma. Fraiser Kansteiner Sep 18, 2024 12:11pm. Connect.
The top 20 pharma companies by 2021 revenue
WEBIt was a good year to be a pharmaceutical company, especially one that came up with a product to combat COVID-19. Of the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% ...
The top 10 most profitable pharma companies in 2021
WEBThe six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
The top 15 blockbuster patent expirations coming this decade
WEBLooking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
The top 15 best-selling cancer drugs in 2022 | Fierce Pharma
WEBIf there was any doubt that the oncology market is set to reach unprecedented heights, FiercePharma's top 15 list of cancer drugs in 2022 should eliminate it. All told, by 2022, the top 15 cancer ...
Marketing - Fierce Pharma
WEB4 days ago · Bayer, Daiichi, argenx leaders on navigating the AI 'hype cycle'. Amid all the AI hype, pharma marketers are taking a more cautious approach to implementing the technology. Andrea Park Sep 18 ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
WEBMar 29, 2021 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
FDA approves Gilead's Livdelzi for primary biliary cholangitis
WEBAug 14, 2024 · The list price for a 10-mg dose of Livdelzi is $12,606 for 30 days, which works out to $151,272 per year. Livdelzi will compete with Intercept Pharmaceuticals’ Ocaliva, which was approved for ...
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
WEBSep 28, 2018 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...